Contact:
Tel:
+44 (0)1492 530607
Mobile:
+44 (0)802 160632
Paper:
Fax:
+44 (0)1492 531490
| KH&A | Kent Hill & Associates Ltd |
DR KENT HILL PhD CBiol MIBiol
About Us
Contact
Us
Healthcare Consultancy
| Your problems? | Our solutions ... |
| Clinical monitoring overload | Temporary CRA resource |
| Site audits needed | Independent clinical QA assessments |
| Reports to write | Off-site medical writing to ICH GCP |
| Project management burden | Expedient planning services |
| European presence lacking | Local EU expertise & contacts |
| CRO selection required | Experience from sponsors' viewpoints |
| Product licensing & divestment needs | Website portfolio of synergistic opportunities |
KH&A is an independent consultancy based in the north west of the UK which advises on strategic aspects of product development and the implementation and management of clinical research programs.
Dr Kent Hill is a graduate pharmacologist with over 25 years experience in the pharmaceutical industry, latterly in clinical research management with several multinational pharmaceutical companies.
A portfolio of confidential services are provided on a consultancy or contract basis to assist R & D-based pharmaceutical, biotechnology and related healthcare companies in evaluating and developing their products. We have particular expertise in advising clients from abroad.
Strategic project planning
The success of a clinical product depends upon identifying its distinctive actions and establishing an unique profile in appropriate therapeutic areas, by a structured programme of clinical studies tailored to the market.
Clinical study design and documentation
Ethical and regulatory considerations, the clinical assessments and methods for safety evaluation influence the study design and procedures for data recording and analysis, as described in the formal study protocol.
Investigator selection, recruitment and monitoring
Our choice of the most appropriate investigators is influenced by the study design, type of patient, the product, regulatory requirements, time scale and study population, with regular monitoring of the study centres by our staff and reporting to the client in accordance with the ICH GCP Guideline.
Data acquisition and analysis
The raw data within the purpose designed case report forms are checked at the study centres for accuracy of completion and verified against source documents and may be provided directly to the client or following appropriate statistical analysis.
Reports and publications
Formal integrated study reports are written to client or our SOPs according to internationally accepted guidelines specified by regulatory authorities. They include the protocol and any amendments, raw data listings, statistical methods and results including adverse events with interpretation of the clinical significance of the findings.
Advice is given on the content of abstracts and manuscripts for submission to appropriate learned societies and journals.
Clinical quality assurance
This increasingly important service is provided by pairs of fully trained auditors for the accepted interrogation and witnessed note taking technique. Site, sponsor study master files and systems audits are conducted from an independent viewpoint. Preparations for and observation of federal regulatory agency inspections is a specialist service to clients.
Product licensing and divestment
We offer independent experience in product licensing and divestment for clients on an international basis. For further infationrmation on current opportunities, we suggest visits are paid to our regularly updated Web site.
Location
We are within 1 hour by car from Manchester International Airport with direct flights from all domestic, European, Scandinavian and many overseas cities. Situated on a Roman highway, we are fortunate to enjoy a pleasant coastal environment with the backdrop of Snowdonia.
|
Kent Hill & Associates Ltd |
|
Contact: |
Tel: |
|
|
Mobile: |
|
Paper: |
Fax: |
E-mail kenthill@dial.pipex.com
Website http://dspace.dial.pipex.com/kenthill/
| KH&A |
DR KENT HILL PhD CBiol
MIBiol UP
Dr Hill's basic graduate training and early experience as a research pharmacologist was the foundation of his career in the pharmaceutical Industry. Immediately after completing his PhD he managed a number of clinical research projects for pharmaceutical companies on an international basis. He established a small CRO and worked on a consultancy basis to the pharmaceutical and biotechnology healthcare sectors, widening his experience in several overseas markets. He has the ability to recognise opportunities for potential products to be turned into real business opportunities. He is able to work independently using his own initiative, or in a team environment with scientists, physicians, technologists or business people. |
SUMMARY CAREER HISTORY
1997 - 1998 CORTECS INTERNATIONAL
CLINICAL RESEARCH MANAGER
Managed clinical trials of two potential therapeutics and a diagnostic product on a local UK and international [USA and Australia] basis.
1993 - 1997 AMERSHAM INTERNATIONAL
SENIOR CLINICAL RESEARCH ASSOCIATE
Managed Phase IV clinical trials programme of MyoviewTM in Europe and Middle East.
1992 - 1993 HOFFMANN - LA ROCHE AG
CLINICAL AUDITOR
Audited clinical trials in several therapeutic areas in Europe, Far East and Australia.
1987 - 1992 SAROS LIMITED
MANAGING DIRECTOR
Managed this pharmaceutical and biotechnology sector consultancy.
1986 - 1987 BOEHRINGER MANNHEIM UK LIMITED
CLINICAL RESEARCH MANAGER
UK phase III clinical trials in three therapeutic areas, managed 7 CRO's.
EDUCATION AND QUALIFICATIONS
| Charing Cross Hospital Medical School | PhD Renal autoregulation | Pass |
| NESCOT M I Biol | Physiology and Pharmacology | 2.1 |
| NESCOT L I Biol | Applied Biology | Pass |
| NESCOT | Higher National Diploma Applied Biology | Pass |
MEMBERSHIPS
Member of the Association for Clinical Research in the Pharmaceutical Industry